Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Recruitment status now shows no more participants; new user guidance sections were added, and the Intervention/Treatment header formatting was updated to reflect the current structure of the study details.
    Difference
    0.4%
    Check dated 2026-06-14T05:14:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The study record shows a new revision (v3.5.5) replacing the previous revision (v3.5.4), indicating an updated page version rather than new study data.
    Difference
    0.1%
    Check dated 2026-06-07T00:24:59.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.5.3 to v3.5.4, indicating a small build/version update.
    Difference
    0.1%
    Check dated 2026-05-16T09:30:01.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T22:19:48.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:11.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0; removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:50:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.